Dr. Tanaka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Dept of Internal Medicine
Iowa City, IA 52242Phone+1 319-356-4901Fax+1 319-384-8559
Education & Training
Nagoya University - School of MedicineClass of 2005
Certifications & Licensure
IA State Medical License 2015 - 2025
Publications & Presentations
PubMed
- 237 citationsEffect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infectionYasuhiro Asahina, Kaoru Tsuchiya, Nobuharu Tamaki, Itsuko Hirayama, Tomohiro Tanaka
Hepatology. 2010-08-01 - 11 citationsDecision tree analysis to stratify risk of de novo non-melanoma skin cancer following liver transplantationTomohiro Tanaka, Michael D. Voigt
Journal of Cancer Research and Clinical Oncology. 2018-01-23 - 8 citationsTreatment with ribavirin for chronic hepatitis E following living donor liver transplantation: A case reportTomohiro Tanaka, Nobuhisa Akamatsu, Yoshihiro Sakamoto, Yuki Inagaki, Yukio Oshiro
Hepatology Research. 2016-01-26
Press Mentions
Mefloquine: A Promising Drug 'Soldier' in the Battle Against COVID-19July 2nd, 2021- Tokyo University of Science & Collaborators Find Mefloquine Could Target COVID-19July 2nd, 2021
- The Dream Team: Drug Duo May Cure COVID-19June 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
